Hyperlipidemia in children: The role of uremia, steroids and cyclosporine therapy

Nephron

Volumn 74, Issue 3, 1996, Pages 529-535

  Singh, Anup ^a   Tejani, Amir ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Children; Cyclosporine; Lipid profile; Prednisone; Uremia

Indexed keywords

CHOLESTEROL; CYCLOSPORIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOSUPPRESSIVE AGENT; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PREDNISONE; STEROID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULOSCLEROSIS; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; UREMIA;

EID: 0029988297     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189447     Document Type: Article

References (38)

1. Tejani A, Sullivan K, Alexander S, Fine R, Harmon W, Lilienfcld D: Posttransplant deaths and factors that influence mortality rate in North American Children, Transplantation 1994:57:1-5.
2. Fricdewald W, Levy R, Fredrickson D: Estimation of the concentration of low-dcnsitv lipoprotein cholesterol in plasma, without use of preparative ultracentrifugc, Clin Chem 1972: 18:499-501.
3. Ross R: The pathogenesis of atherosclerosis-An update, N Engl J Med 1986;314:488-500.
4. Grundy SM: Cholesterol and coronary artery disease: A new era, JAMA 1986:256:2848-2858.
5. Grundy SM: Management of hyperlipidemia in kidney disease, Kidnev Int 1990;37:847-853.
6. Greaves SC, Sharpe DN: Cardiovascular disease in patients with end-stage renal failure, AustNZJ Med 1992:22:153-159.
7. Masmaron J, Caralps A, Llorach M: Hyperlipidemia after renal transplantation, Lancet 1975;Vol i: 1090-1092.
8. Ibels LS, Alfrey AC, Weil R: Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients, Am J Med 1978;64:634-642.
9. Ponticelli C, Barbi GL, et al: Lipid disorders in renal transplant recipients, Nephron 1978:20: 189-195.
10. Cattran DC, Steiner G, et al: Hyperlipidemia after renal transplantation: Natural history and pathophysiology, Ann Intern Med 1979:91: 554-559.
11. Bagdadc J, Casaretto A, Albers J: Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man, J Lab Clin Med 1976:87:37-48.
12. Pennisi AJ, Heuser WT, et al: Hyperlipidemia in pediatric hemodialysis and renal transplant patients associated with coronary artery disease, Am J Dis Child 1976:130:957-961.
13. Asavama K, Ito H, et al: Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation, Pediatr Res 1984:18:783-788.
14. Van Gool S, Van Dam-Lormbacrts R, et al: Lipid and lipoprotein abnormalities in children on hemodialysis and after transplantation, Transplant Proc 1991:23:1375-1377.
15. Tejani A, et al: North American Pediatric Renal Transplant Cooperative Study, 1994 Annual Report, vol 18.
16. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, et al, A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome, Kidney Int 1993:43:1377-1384.
17. Ingulli E, Tejani A, Marked M: The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era, Transplantation 1993:55:1029-1033.
18. Maiorca R, Cristinelli L, Brunori G, Setti G, Salcrni B, De Nobili U, Mittempergher F: Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine, Transplant Proc 1988;20(suppl): 121-125.
19. Hrieik DE, Mayes JT, Schulak JA: Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia, Am Kidney Dis 1991:18:353-358.
20. Schorn TF, Kliem V, Bojanovski M, Bojanovs-ki D, Repp H, Bunzendahl H, Frci U: Impact of long-term immunosuppression with cyclosporine A on serum lipids in stable renal transplant patients, Transplant Int 1991;4:92-95.
21. Gregg R, Diamond A, Mondond C, Rcavcn G: Effects of moderate azotemia and glucocorticoid therapy on triglyceride metabolism in the rat, Clin Res 1976:24:131A.
22. Hays AP, Hill RB Jr: Enzymes of lipid synthesis in the liver of cortisone-treated rat, Biochim BiophysActa 1965:98:646.
23. Bagdadc JD, Yee E, Albers J, et al: Impaired triglyceride removal: A mechanism of steroid-induced lipemia, Clin Res 1975;23:134A.
24. Rcavcn EP, Koltcrman OG, Reavcn GM: Ultrastructural and physiological evidence of corticosteroid-induced alterations in hepatic production of very low density particles, J Lipid Res 1974:15:74.
25. Berg AL, Nilsson-Ehle P: ACTH lowers serum lipids in steroid-treated hyperlipidémie patients with kidney disease, J Am Soc Nephrol 1994;5:325(abstract).
26. Dahlen GH, Guyton JR, Attar M, et al: Association of levels of lipoprotein (a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography, Circulation 1986;74:758-765.
27. Edelbcrg J, Pizzo SV; Lipoprotein (a) regulates plasmin generation and inhibition, Chem Phys Lipids 1994:67/68:363-368.
28. Tyrcll J, Cooke T, Reilly M, et al: Lipoprotein (a) and peripheral vascular disease, J Intern Med 1992;232:349-352.
29. Haffner SM, Gruber KK, Aldrete G Jr, et al: Increased lipoprotein (a) concentration in chronic renal failure, J Am Soc Nephrol 1992: 3:1156-1162.
30. Heimann P, Josephson MA, Fcllncr SK, et al: Elevated lipoprotein (a) levels in renal transplantation and hemodialysis patients, Am J Nephrol 1991:11:470-474.
31. Brown JH, Anwar N, Short CD, et al: Serum lipoprotein (a) in renal transplant recipients receiving cyclosporine monotherapy, Nephrol Dial Transplant 1993;8:863-867.
32. Kinosian B, Glick H, Garland G: Cholesterol and coronary heart disease: Predicting risks by levels and ratios, Ann Intern Med 1994; 121: 641-647.
33. Kasiske BL, O'Donnell MP, Schimtz PG, Kim Y, Keane WF: The renal injury of diet-induced hypercholesterolemia in rats, Kidnev Int 1990; 37:880-891.
34. Tolins JP, Stone BG, Raij L: Interaction of hypercholesterolemia and hypertension in initiation of glomerular injury, Kidney Int 1992; 41:1254-1261.
35. Ingulli E, Tejani A: Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children, Pediatr Nephrol 1991:5:393-397.
36. Ellis D, Shapiro R, Jordan ML, Scantlcbury VP, Gilboa N, Hopp L, Weichlcr N, Tzakis AG, Simmons RL: Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation, Pediatr Nephrol 1994;8:193-200.
37. Stepkowski SM, Kahan BD: Rapamycin and cyclosporine synergisticallv prolong heart and kidney allograft survival, Transplant Proc 1991:23:3262-3264.
38. Robertson A, Plcnter R, Francis DM, Clunie GJ: Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin, Transplant Proc 1993:25:2898-2899.